Reaction
Intussusception reporting signals
As of the last recalculation, Intussusception appears in 938 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is SIROLIMUS (PRR 70.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sirolimus | 41 | 70.6 | 70.8 |
| Ganciclovir | 25 | 55.7 | 55.8 |
| Ganciclovir Sodium | 25 | 53.8 | 54.0 |
| Pegaspargase | 19 | 35.1 | 35.2 |
| Valganciclovir Hydrochloride Powder, | 13 | 24.0 | 24.0 |
| Vincristine Sulfate | 27 | 21.0 | 21.0 |
| Indomethacin | 12 | 20.3 | 20.4 |
| Valganciclovir | 15 | 17.9 | 17.9 |
| Valganciclovir Hydrochloride | 15 | 17.9 | 17.9 |
| Teduglutide | 10 | 16.6 | 16.6 |
| Ritonavir 100 Mg | 10 | 15.0 | 15.0 |
| Cytarabine | 39 | 15.0 | 15.0 |
| Ifosfamide | 13 | 13.6 | 13.6 |
| Temozolomide | 12 | 12.8 | 12.8 |
| Atazanavir | 8 | 12.5 | 12.5 |
| Lumacaftor And Ivacaftor | 3 | 7.8 | 7.8 |
| Palivizumab | 5 | 7.3 | 7.3 |
| Dornase Alfa | 6 | 6.8 | 6.8 |
| Ipilimumab | 12 | 6.2 | 6.2 |
| Isotretinoin | 12 | 5.4 | 5.4 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 3 | 5.4 | 5.4 |